FDA OKs Platelet Booster for Liver Disease Patients

Avatrombopag increases platelet counts and may decrease or eliminate the need for transfusions in patients with liver disease and thrombocytopenia who are to undergo a planned medical or dental procedure.
News Alerts

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply